James Ahern
Managing Partner, Head of Capital Markets @ Laidlaw & Company
New York, United States
James Ahern is a Series B investor at Laidlaw & Company in New York focused on Biopharma and Health Care. James Ahern serves as managing partner of Laidlaw & Company, an investment bank focused on the health care sector. Since joining the firm in 2010, he has worked to make it a leading institutional investor throughout the world, establishing a network of offices throughout the United States and Europe. He has extensive experience guidingmultimillion-dollar equity investments from initial offering through to closing. Prior to his position at Laidlaw & Company, James Ahern served as managing director of Aegis Capital, where he produced bespoke investment strategies for high net worth clientele. Outside of his professional life, Jimmy gives back to his community as a supporter of a number of charitable organizations. He is a longtime volunteer and supporter of the Massachusetts Bay Big Brothers Sisters Foundation and serves on the organization’s board of overseers. He previously served as co-chair of the Big Brothers Big Sisters of Massachusetts Bay Golf Classic, helping to raise $750,000 for the organization. An alumni of the Northfield Mount Hermon School, he continues to contribute regularly to the school and is the current chair of the school’s Basketball Alumni Council of Excellence.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries James Ahern invests in
Stages James Ahern invests in
Countries James Ahern invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biopharma 1 (100%)
- Health Care 1 (100%)
- Biotechnology 1 (100%)
- Pharmaceutical 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Algorithm Sciences is focused on optimizing treatment for rare Cardiovascular Diseases. It is a Laidlaw Venture Partners portfolio company. | $5M / Series B / Apr 20, 2021 |
About Laidlaw & Company
Laidlaw & Company providing comprehensive investment banking services to emerging growth companies and wealth management services to institutions and individuals.”170 year legacy of independent investment banking and securities brokerage focused on the needs of domestic and international companies, corporate entrepreneurs, institutions andprivate clients worldwide.
Laidlaw & Company Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Hugh Regan
Director
|
|||
|
James Ahern
Managing Partner, Head of Capital Markets
|
|||
Jeffrey F. O'Donnell
Venture Partner
|
|||
Matt Eitner
Chief Executive Officer
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does James Ahern invest in?
James Ahern invests primarily in Biopharma, Health Care and Biotechnology startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact James Ahern?
Public channels for James Ahern include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did James Ahern last invest?
The most recent investment recorded for James Ahern closed in Apr 2021. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
